Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy

Plasma levels of kisspeptin have been suggested as a biomarker for miscarriage. This study demonstrates kisspeptin assay stability in serum and its potential clinical utility as a biomarker for early pregnancy viability.